Breath analysis: Potential for clinical diagnosis and exposure assessment

Clinical Chemistry

Volumn 52, Issue 5, 2006, Pages 800-811

  Cao, Wenqing ^a   Duan, Yixiang ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VOLATILE ORGANIC COMPOUND;

BREATH ANALYSIS; DIAGNOSTIC TEST; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; LUNG DISEASE; METABOLIC DISORDER; MONITORING; OXIDATIVE STRESS; REVIEW; RISK ASSESSMENT; SAMPLING; UREA BREATH TEST;

BREATH TESTS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; GASTROINTESTINAL DISEASES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LUNG DISEASES; METABOLIC DISEASES; OXIDATIVE STRESS;

HELICOBACTER PYLORI;

EID: 33646338915     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.063545     Document Type: Review

References (125)

1. Amann A, Schmid A, Scholl-Burgi S, Telser S, Hinterhuber H. Breath analysis for medical diagnosis and therapeutic monitoring. Spectroscopy Europe 2005;17:18-20.
2. 13C-Urea breath test in the diagnosis of Helicobacter pylori infection-a critical review. Aliment Pharmacol Ther 2004;20:1001-17.
3. Logan RPH. Urea breath tests in the management of Helicobacter pylori infection [Review]. Gut 1998;43(Suppl 1):S47-50.
4. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002;97: 1113-26.
5. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis: focus on volatile organic compounds. Clin Chim Acta 2004;347:25-39.
6. Rosias PPR, Dompeling E, Dentener MA, Pennings HJ, Hendriks HJE, Van Iersel MPA, et al. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004;38:107-14.
7. Stick SM. Non-invasive monitoring of airway inflammation. Med J Aust 2002;177(Suppl):S59-60.
8. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo R. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Appl 1999;729:75-88.
9. Schubert JK, Miekisch W, Geiger K, Noldge-Schomburg GF. Breath analysis in critically ill patients: potential and limitations. Expert Rev Mol Diagn 2004;4:619-29.
10. Mukhopadhyay R. Don't waste your breath. Researchers are developing breath tests for diagnosing diseases, but how well do they work? Anal Chem 2004;76:273A-6A.
11. Pleil JD, Lindstrom AB. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds. Clin Chem 1997;43:723-30.
12. Phillips M. Breath tests in medicine. Sci Am 1992;267:74-9.
13. Manolis A. The diagnostic potential of breath analysis. Clin Chem 1983;29:5-15.
14. Kobayashi T, Seguchi H. Novel insight into current models of NADPH oxidase regulation, assembly, and localization in human polymorphonuclear leukocytes. Histol Histopathol 1999;14: 1295-308.
15. Gredilla R, Phaneuf S, Selman C, Kendaiah S, Leeuwenburgh C, Barja G. Short-term caloric restriction and sites of oxygen radical generation in kidney and skeletal muscle mitochondria. Ann N Y Acad Sci 2004;1019:333-42.
16. Metidiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurological disorders: an overview. Neurotox Res 2000;1:197-233.
17. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003;88:1082-8.
18. Izumi M, McDonald MC, Sharpe MA, Chatterjee PK, Thiemermann C. Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 2002;18: 230-5.
19. Phillips M, Cataneo RN, Cheema T, Greenberg, J. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta 2004;344:189-94.
20. Moretti M, Phillips M, Abouzeid A, Cataneo RN, Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol 2004;190: 1184-90.
21. Phillips M, Cataneo RN, Greenberg J, Gunawardena R, Rahbari-Oskoui F. Increased oxidative stress in younger as well as in older humans. Clin Chim Acta 2003;328:83-6.
22. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med 2000;28:880-6.
23. Risby TH, Sehnert SS. Clinical application of breath biomarkers of oxidative stress status. Free Radic Biol Med 1999;27:1182-92.
24. Dumelin EE, Tappel AL. Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides. Lipids 1977;12:894-900.
25. Aghdassl E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 2003;98:348-353.
26. Scholpp J, Schubert JK, Mleklsch W, Geiger K. Breath markers and soluble lipid peroxidation markers in critically ill patients. Clin Chem Lab Med 2002;40:587-94.
27. Horvath I, MacNee W, Kelly FJ, Dekhuijzen PNR, Phillips M, Doring G, et al. Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases: summary of the ERS research seminar in Budapest. Eur Respir J 2001;18:420-30.
28. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003;124:1373-80.
29. Antczak A. Markers of oxidative stress in exhaled breath condensate. NATO Science Series, Series 1: Life Behav Sci 2002;346: 333-7.
30. Lases EC, Duurkens VAM, Gerritsen WB, Haas FJ. Oxidative stress after lung resection therapy: a pilot study. Chest 2000; 117:999-1003.
31. Phillips M, Cataneo RN, Greenberg J, Grodman R, Gunawardena R, Naidu A. Effect of oxygen on breath markers of oxidative stress. Eur Respir J 2003;21:48-51.
32. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000;162: 1450-4.
33. Paredi P, Kharltonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:369-73.
34. Olopade CO, Christon JA, Zakkar M, Hua CW, Swedler WI, Scheff PA, et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997;111:1500-4.
35. Schubert JK, Müller WPE, Benzing A, Geiger K. Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med 1998;24:415-21.
36. Kharitonov SA, Chung FK, Evans DJ, O'Connor BJ, Barnes PJ. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996;153:1773-80.
37. Hamid Q, Springall DR, Riverosmoreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
38. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998;12:929-37.
39. Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN, Israel E, et al. Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med 2000;162:2043-7.
40. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999;159:1810-3.
41. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? [Review]. Swiss Med Wkly 2004; 134:175-92.
42. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the accuracy of exhaled nitric oxide for the diagnosis of asthma [Abstract]. Am J Respir Crit Care Med 1999;159:A861.
43. Ekroos H, Tuominen J, Sovijarvi AR. Exhaled nitric oxide and its long-term variation in healthy non-smoking subjects. Clin Physiol 2000;20:434-9.
44. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003;123:751-6.
45. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
46. Kharitonov SA, Robbins RA, Yates DH, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609-12.
47. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162:701-6.
48. Clini E, Bianchi L, Pagani M, Ambrosino N. Endogenous nitric oxide in stable COPD patients: correlates with severity of disease. Thorax 1998;53:881-3.
49. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:998-1002.
50. Fisher AJ, Gabbay E, Small T, Doig S, Dark JH, Corris PA. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998;53:454-8.
51. Phillips M, Cataneo RN, Cummin ARC, Gagliardi AJ, Gleeson K, Greenberg J, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003;123:2115-23.
52. Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999;353: 1930-3.
53. Studer SM, Orens JB, Rosas I, Krishnan JA, Cope KA, Yang S, et al. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant 2001;20:1158-66.
54. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005;356:22-34.
55. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997;156:1140-3.
56. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Sasaki H. Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J 1999;13:757-60.
57. Uasaf C, Jatakanon A, James A, Kharitonov SA, Wilson NM, Barnes PJ. Exhaled carbon monoxide in childhood asthma. J Pediatr 1999;135:569-74.
58. Paredi P, Shah P, Montuschi P, Sullivan P, Hodson ME, Kharitonov SA, et al. Increased carbon monoxide in exhaled air of cystic fibrosis patients. Thorax 1999;54:917-20.
59. Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000;55:138-42.
60. Jöbsis Q, Raatgeep HC, Hermans PWM, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997;10:519-521.
61. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997;10:1235-41.
62. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, et al. Increased exhalation of hydrogen peroxide in-patients with stable and unstable chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 1996;154(3 Pt 1):813-6.
63. Nowak D, Kasielski M, Pietras T, Bialasiewicz P, Antczak A. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis 1998;53:268-73.
64. Worlitzsch D, Herberth G, Ulrich M, Doring G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998;11:377-83.
65. Ho LP, Faccenda J, Innes JA, Greening AP. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999;13:103-6.
66. Montuschi P, Ciabattoni G, Corradi M, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensates of asthmatic patients. Am J Respir Crit Care Med 1999;160:216-20.
67. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-7.
68. Montuschi P, Kharitonov SA, Ciabattoni G, Corradi M, van Rensen L, Geddes DM, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000;55:205-9.
69. Hunt J, Byrns RE, Ignarro LJ, Gaston B. Condensed expirate nitrite as a home marker for acute asthma. Lancet 1995;346: 1235-6.
70. Corradi M, Montuschi P, Donnelly LE, Hodson ME, Kharitonov SA, Barnes PJ. Nitrosothiols and nitrite in exhaled breath condensate of patients with cystic fibrosis [Abstract]. Am J Respir Crit Care Med 1999;159:A682.
71. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis in contrast to exhaled nitric oxide. Thorax 1998;53:680-4.
72. Clarke JTR. A Clinical Guide to Inherited Metabolic Diseases. Cambridge: Cambridge University Press, 1996:2.
73. Glanze WD, Anderson KN, Anderson LE, Urdang L, Swallow HH. Mosby's Medical and Nursing Dictionary, 2nd ed. Toronto: CV Mosby, 1986:707.
74. Kalapos MP. Possible physiological roles of acetone metabolism in humans. Med Hypotheses 1999;53:236-42.
75. Taylor R, Agius L. The biochemistry of diabetes. Biochem J 1988;250:625-40.
76. Henderson MJ, Karger BA, Wrenshall GA. Acetone in the breath: a study of acetone exhalation in diabetic and nondiabetic human subjects. Diabetes 1952;1:188-93.
77. Lord H, Yu YF, Segal A, Pawliszyn J. Breath analysis and monitoring by membrane extraction with sorbent interface. Anal Chem 2002;74:5650-7.
78. Smith D, Spanel P, Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. J Appl Physiol 1999;87:1584-8.
79. Sulway MJ, Malins JM. Acetone in diabetic ketoacidosis. Lancet 1970;1:736-40.
80. Crofford OB, Mallard RE, Winton RE, Rogers NL, Jackson JC, Keller U. Acetone in breath and blood. Trans Am Clin Climatol Assoc 1977;88:128-39.
81. Sanchez JM, Sacks RD. GC analysis of human breath with a series-coupled column ensemble and a multibed sorption trap. Anal Chem 2003;75:2231-6.
82. Perman JA. Clinical application of breath hydrogen measurements. Can J Physiol Pharmacol 1991;69:111-5.
83. Bauer TM, Schwacha H, Steinbruckner B, Brinkmann FE, Ditzen AK, Kist M, et al. Diagnosis of small intestinal bacterial over-growth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000;33:382-6.
84. Nieminen U, Gylling H, Icen A, Farkkila MA. Lactose malabsorption: use of breath hydrogen test and serum glucose analyses in diagnostics [Abstract]. Gastroenterology 2000;118:A1132.
85. Katicic M, Presecki V, Kalenic S, Dominis M. Helicobacter pylori: introduction and review of research. Lijec Vjesn 2002;124(Suppl 1):1-5.
86. Marshall B, Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
87. Irving CS, Wong WW, Shulman RJ, Smith EO, Klein PD. [13C]Bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol 1983;245:R190-202.
88. Irving CS, Wong WW, Wong WM, Boutton TW, Shulman RJ, Lifschitz CL, et al. Rapid determination of whole-body bicarbonate kinetics by use of a digital infusion. Am J Physiol 1984;247(4 Pt 2):R709-16.
89. Irving CS, Lifschitz CH, Wong WW, Boutton TW, Nichols BL, Klein PD. Characterization of bicarbonate-carbon dioxide pool sizes and kinetics in infants. Pediatr Res 1985;19:358-63.
90. Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc 1994;40:342-5.
91. Brown KE, Peura DA. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:105-15.
92. 14C urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol 1996;91: 233-8.
93. Cutler AF, Havstad S, Ma C, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
94. 13C urea breath test. J Clin Gastroenterol 1999;28:238-40.
95. Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996;91:2125-9.
96. 13C-urea breath test for the detection of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:747-52.
97. Folke M, Cernerud L, Ekstrom M, Hok B. Critical review of non-invasive respiratory monitoring in medical care. Med Biol Eng Comput 2003;41:377-83.
98. Nadkarni UB, Shah AM, Deshmukh CT. Non-invasive respiratory monitoring in paediatric intensive care unit. J Postgrad Med 2000;46:149-52.
99. 2 in extubated patients recovering from general anesthesia. J Clin Monit 1992;8:226-30.
100. Santos LJ, Varon J, Pic-Aluas L, Combs AH. Practical uses of end-tidal carbon dioxide monitoring in the emergency department. J Emerg Med 1994;12:633-44.
101. Wiedemann HP, McCarthy K. Noninvasive monitoring of oxygen and carbon dioxide. Clin Chest Med 1989;10:239-54.
102. Wells J, Koves E. Detection of carbon disulphide (a disulfiram metabolite) in expired air by gas chromatography. J Chromatogr 1974;92:442-4.
103. McCarthy TJ, Van Zyl JD. Breath analysis of cannabis smokers. J Pharm Pharmacol 1972;24:489-90.
104. Valentine JL, Bryant PJ, Gutshall PL, Owen HMG, Niu HC. Detection of 9-tetrahydrocannabinol in human breath following marijuana smoking. Anal Lett 1979;12:867-80.
105. Block RI, Erwin WJ, Farinpour R, Braverman K. Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques. Pharmacol Biochem Behav 1998;59:405-12.
106. Loughnan TE, Monagle J, Copland JM, Ranjan P, Chen MF. A comparison of carbon dioxide monitoring and oxygenation between facemask and divided nasal cannuia. Anaesth Intensive Care 2000;28:151-4.
107. Roy J, McNulty SE, Torjman MC. An improved nasal prong apparatus for end-tidal carbon dioxide monitoring in awake, sedated patients. J Clin Monit 1991;7:249-52.
108. Riker JB, Haberman B. Expired gas monitoring by mass spectrometry in a respiratory intensive care unit. Crit Care Med 1976;4:223-9.
109. Committee on Advances in Assessing Human Exposure to Airborne Pollutants, National Research Council, National Academy of Sciences. Human Exposure Assessment for Airborne Pollutants: Advances and Opportunities. Washington, DC: National Academies Press, 1991:344pp.
110. Wallace LA. Human exposure to volatile organic pollutants: implications for indoor air studies. Annu Rev Energy Environ 2001;26:269-301.
111. Krotoszynski BK, Bruneau GM, O'Neill HJ. Measurement of chemical inhalation exposure in urban populations in the presence of endogenous effluents. J Anal Toxicol 1979;3:225-34.
112. Pellizzari ED, Zweidinger RA, Sheldon LS. Breath sampling for environmental carcinogens: methods of analysis and exposure measurement. In: Seifert B, Van de Wiel HJ, Dodet B, O'Neill IK, eds. Indoor Air, Vol. 12. Lyon, France: World Health Organization, 1993:228-36.
113. Gargas ML, Burgess RJ, Voisard DE, Carson GH, Andersen ME. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 1989;98: 87-99.
114. Sato A, Nakajima T. Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health 1987; 13:81-93.
115. Brugnone F, Perbellini L, Faccini GB, Pasini F. Benzene in the breath and blood of normal people and occupationally exposed workers. Am J Ind Med 1989;16:385-99.
116. Perbellini I, Faccini GB, Pasini F, Cazzoli F, Pistoia S, Rosellini R, et al. Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med 1988;45:345-52.
117. Wallace L, Buckley T, Pellizzari E, Gordon S. Breath measurements as volatile organic compound biomarkers. Environ Health Perspect 1996;104(Suppl 5):861-9.
118. Teorell T. Kinetics of distribution of substances administered to the body. I: the extravascular modes of administration. Arch Int Pharmacodyn 1937;57:205-25.
119. Wallace L, Pellizzari E, Gordon S. A linear model relating breath concentrations to environmental exposures: application to a chamber study of 4 volunteers exposed to volatile organic chemicals. J Expo Anal Environ Epidemiol 1993;3:75-102.
120. Ramsey JC, Andersen ME. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 1984;73:159-75.
121. Soldat KL, Thrall KD. Design and evaluation of a breath analysis system for occupational exposure assessment. Environ Health Risk 2001;2001:83-92.
122. Bois FY, Woodruff TJ, Spear RC. Comparison of three physiologically based pharmacokinetic models of benzene disposition. Toxicol Appl Pharmacol 1991;110:79-88.
123. Adlkofer F. Lung cancer due to passive smoking: a review. Int Arch Occup Environ Health 2001;74:231-41.
124. Moya J, Howard CL, Corsi RL. Volatilization of chemicals from tap water to indoor air while showering with contaminated water. Environ Sci Technol 1999;33:2713-21.
125. Wallace LA, Pellizzari ED, Hartwell TD, Davis V, Michael LC, Whitmore RW. The influence of personal activities on exposure to volatile organic compounds. Environ Res 1989;50:37-55.